Results 311 to 320 of about 166,962 (340)
Hyaluronic Acid-Based Nanomotors: Crossing Mucosal Barriers to Tackle Antimicrobial Resistance. [PDF]
ACS Appl Mater InterfacesRuiz-González N +4 more
europepmc +1 more source
Hyaluronic acid: Hope or hype in periodontics - A narrative review.
J Indian Soc PeriodontolSahu PP, Uppoor AS, Nayak SU.
europepmc +1 more source
Structure for Hyaluronic Acid [PDF]
Nature New Biology, 1972 THE mucopolysaccharide hyaluronic acid exists naturally as a hydrated gel. It is the constituent of synovial fluid which acts as a lubricant; it also occurs in the vitreous humour where its function is probably to maintain the precise shape of the eye. Chemically it is a regular, unbranched polymer with a repeating unit of the type (-N-G-)n where N is ...
J. K. Sheehan, Edward D. T. Atkins
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biopolymers, 1968
AbstractThe dynamic viscoelastic properties of hyaluronic acid solutions have been measured over the frequency range 0.02–1.67 cps. The effects of varying temperature, hyaluronic acid concentration, pH, and ionic strength on the dynamic shear moduli were studied.
E. W. Merrill +3 more
openaire +3 more sources
AbstractThe dynamic viscoelastic properties of hyaluronic acid solutions have been measured over the frequency range 0.02–1.67 cps. The effects of varying temperature, hyaluronic acid concentration, pH, and ionic strength on the dynamic shear moduli were studied.
E. W. Merrill +3 more
openaire +3 more sources
Bacteriostatic Effects of Hyaluronic Acid [PDF]
Journal of Periodontology, 1999 Background: This investigation is one of a series of projects seeking to ascertain whether hyaluronic acid (HA) is therapeutically effective in tissue regeneration procedures. The rationale for these investigations is to test the hypothesis that HA can serve as a bioabsorbable carrier for other substrates as well as itself actively promote the ...
Payman Pirnazar +5 more
openaire +3 more sources
Dermatologic Therapy, 2006
Although hyaluronic acids are a relatively new treatment for facial lines and wrinkles, they have provided numerous advances in the area of cosmetic surgery. This article discusses the inherent properties of hyaluronic acid fillers that make them ideal for treatment of facial lines. It encompasses a review of the current literature on U.S.
Kyle M. Coleman, Gary D. Monheit
openaire +3 more sources
Although hyaluronic acids are a relatively new treatment for facial lines and wrinkles, they have provided numerous advances in the area of cosmetic surgery. This article discusses the inherent properties of hyaluronic acid fillers that make them ideal for treatment of facial lines. It encompasses a review of the current literature on U.S.
Kyle M. Coleman, Gary D. Monheit
openaire +3 more sources
Clinics in Plastic Surgery, 2006
Hyaluronic acids (HAs) are the most versatile fillers on the market. Since their approval in Canada in 1998 and the United States in 2003, applications for facial contouring have been varied, with predictable and outstanding results. Numerous publications support their safety, durability, longevity, and application to reconstructive and cosmetic ...
openaire +2 more sources
Hyaluronic acids (HAs) are the most versatile fillers on the market. Since their approval in Canada in 1998 and the United States in 2003, applications for facial contouring have been varied, with predictable and outstanding results. Numerous publications support their safety, durability, longevity, and application to reconstructive and cosmetic ...
openaire +2 more sources
Drugs & Aging, 1999
Topical gel containing 3% diclofenac in 2.5% hyaluronic acid (HYAL CT1101) is used for the treatment of actinic keratosis. In animal models, diclofenac in hyaluronic acid inhibited angiogenesis and induced neovascular regression in inflammatory tissue, and depleted substance P content in snout tissue.
Dene C. Peters, Rachel H. Foster
openaire +3 more sources
Topical gel containing 3% diclofenac in 2.5% hyaluronic acid (HYAL CT1101) is used for the treatment of actinic keratosis. In animal models, diclofenac in hyaluronic acid inhibited angiogenesis and induced neovascular regression in inflammatory tissue, and depleted substance P content in snout tissue.
Dene C. Peters, Rachel H. Foster
openaire +3 more sources